Autologous EphA2-targeting CAR-DC vaccine loaded with TP53 mutant peptide

TP53-EphA-2-CAR-DC

Report date: 2025/04/09 15:47:22

Base Information

Drug NameAutologous EphA2-targeting CAR-DC vaccine loaded with TP53 mutant peptide
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPla General HospitalZhejiang University
China Registration ClassN/A

Develop Information

Active CompaniesPla General HospitalZhejiang University
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A